PharmaCyte Biotech (PMCB) Accounts Payables (2009 - 2026)
PharmaCyte Biotech's Accounts Payables was $390,535 in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 16.1% from $465,209 a year earlier but up 44.1% from the prior quarter.
PharmaCyte Biotech (PMCB) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Accounts Payables at PharmaCyte Biotech came in at $271,102, down 32.1% from FY2025.
- Accounts Payables shows a five-year compound annual growth rate of 9.5% (FY2021 to FY2026).
- In earlier fiscal years, Accounts Payables was $399,204 in FY2025 (-45.7%), $735,199 in FY2024 (+473.1%), $128,281 in FY2023 (-37.5%) and $205,361 in FY2022 (+19.2%).
- Quarterly Accounts Payables has moved between $92,861 (fiscal Q3 2022) and $1.2 million (fiscal Q3 2026) over five years.
- Compared with a year earlier, Accounts Payables was higher in four of the last eight quarters, with growth averaging 50.9%.
- The best year-over-year quarter for Accounts Payables over five years was fiscal Q4 2024 (growth of 473.1%); the worst was fiscal Q2 2024 (a decline of 85.4%).
- Per Business Quant data, PMCB's Accounts Payables in the three fiscal quarters before Q1 2027 was $271,102 (Q4 2026), $1.2 million (Q3 2026) and $1.02 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -23.57 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | 390,535.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 390,535.00 |
| Apr 30, 2026 | 271,102.00 |
| Jan 31, 2026 | 1.20 Mn |
| Oct 31, 2025 | 1.02 Mn |
| Jul 31, 2025 | 465,209.00 |
| Apr 30, 2025 | 399,204.00 |
| Jan 31, 2025 | 484,948.00 |
| Oct 31, 2024 | 348,595.00 |
| Jul 31, 2024 | 553,952.00 |
| Apr 30, 2024 | 735,199.00 |
| Jan 31, 2024 | 484,198.00 |
| Oct 31, 2023 | 126,163.00 |
| Jul 31, 2023 | 718,130.00 |
| Apr 30, 2023 | 128,281.00 |
| Jan 31, 2023 | 445,935.00 |
| Oct 31, 2022 | 861,276.00 |
| Jul 31, 2022 | 559,026.00 |
| Apr 30, 2022 | 205,361.00 |
| Jan 31, 2022 | 92,861.00 |
| Oct 31, 2021 | 157,039.00 |
PharmaCyte Biotech Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PMCB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();